Agomelatine (Alto Neuroscience)

阿戈美拉汀 (Alto Neuroscience)

Report date: 2024/12/30 15:49:20

Base Information

Drug NameAgomelatine (Alto Neuroscience)
Drug Alias NameALTO-300
ClassificationSmall molecules
Mechanisms of ActionMelatonin receptor 1A agonistsSerotonin 2c (5-HT2c) receptor antagonistsMelatonin receptor 1B agonists
TargetsMelatonin receptor 1ASerotonin 2c (5-HT2c) receptorMelatonin receptor 1B
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlto Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlto Neuroscience Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A